Efavirenz-based regimen as treatment of advanced AIDS with cryptococcal meningitis

J Acquir Immune Defic Syndr. 2003 May 1;33(1):118-9. doi: 10.1097/00126334-200305010-00019.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Adult
  • Alkynes
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / therapeutic use*
  • Benzoxazines
  • CD4 Lymphocyte Count
  • Cryptococcus neoformans
  • Cyclopropanes
  • Female
  • HIV / genetics
  • HIV / isolation & purification
  • Humans
  • Male
  • Meningitis, Cryptococcal / complications*
  • Meningitis, Cryptococcal / microbiology
  • Oxazines / adverse effects
  • Oxazines / therapeutic use*
  • RNA, Viral / blood
  • Thailand
  • Time Factors

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Oxazines
  • RNA, Viral
  • efavirenz